The MOR-1 Opioid Receptor Regulates Glucose Homeostasis by Modulating Insulin Secretion

AUTOR(ES)

Wen, Ting

FONTE

The Endocrine Society

RESUMO

In addition to producing analgesia, opioids have also been proposed to regulate glucose homeostasis by altering insulin secretion. A considerable controversy exists, however, regarding the contribution of the μ-opioid receptor (MOR-1) to insulin secretion dynamics. We employed congenic C57BL/6J MOR-1 knockout (KO) mice to clarify the role of MOR in glucose homeostasis. We first found that both sexes of MOR-1 KO mice weigh more than wild-type mice throughout postnatal life and that this increase includes preferentially increased fat deposition. We also found that MOR-1 KO mice exhibit enhanced glucose tolerance that results from insulin hypersecretion that reflects increased β-cell mass and increased secretory dynamics in the MOR-1 mutant mice compared with wild type. Analysis of the isolated islets indicated that islet insulin hypersecretion is mediated directly by MOR expressed on islet cells via a mechanism downstream of ATP-sensitive K+ channel activation by glucose. These findings indicate that MOR-1 regulates body weight by a mechanism that involves insulin secretion and thus may represent a novel target for new diabetes therapies.

Documentos Relacionados

• Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
• Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene
• Cholesterol Regulates Glucose-stimulated Insulin Secretion through Phosphatidylinositol 4,5-Bisphosphate*
• The role of aminogenic glucagon secretion in blood glucose homeostasis
• Entrainment of pulsatile insulin secretion by oscillatory glucose infusion.